448 results on '"Powell LW"'
Search Results
2. Haemochromatosis: causes and treatment
3. Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis
4. Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume
5. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis
6. Haemochromatosis (HFE) Gene and Risk of Colorectal, Breast and Prostate Cancer
7. HFE gene and hemochromatosis
8. Increased duodenal expression of divalent-metal transporter-1 and iron-regulated gene-1 in cirrhosis
9. The HealthIron Study: Iron Measures at Baseline and Follow-up from a Longitudinal Study of Modifiers of Hereditary Haemochromatosis
10. Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.
11. A novel mutation in ferroportin 1 is associated with haemochromatosis in a Solomon Islands patient
12. GNPAT Polymorphism rs11558492 Is Not Associated With Increased Severity in a Large Cohort of HFE p.Cys282Tyr Homozygous Patients REPLY
13. GNPAT Variant Is Associated With Iron Phenotype in Healthy Taiwanese Women: A Population Without the HFE C282Y Mutation REPLY
14. Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12-year study
15. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
16. Population screening for HFE-associated haemochromatosis: should we have to pay for our genes?
17. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
18. Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance
19. The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)
20. Non-HFE related haemochromatosis in Australia
21. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention
22. Screening for hereditary haemochromatosis (HHC) in a rheumatology clinic using genotypic markers
23. Elevated serum type IV collagen: a sensitive marker of severe fibrosis / cirrhosis in haemochromatosis
24. Changes in hepatic matrix degradation in prefibrotic and fibrotic haemochromatosis
25. Hemochromatosis: The impact of early diagnosis and therapy
26. The haemochromatosis gene: A global perspective and implications for the Asia–Pacific region.
27. Factors influencing disease expression in hemochromatosis.
28. ALTERATIONS OF DRUG METABOLISM IN RATS EXPOSED TO CIGARETTE SMOKE.
29. Developments in Immobilized-Enzyme Technology
30. ANÆMIA, STEATORRHŒA AND JAUNDICE
31. NORMAL HUMAN IRON STORAGE AND ITS RELATION TO ETHANOL CONSUMPTION
32. THE NORMAL PLANTAR REFLEX
33. The role of radioactive isotopes in the diagnosis of gastro-intestinal disease
34. Bilirubin metabolism and jaundice with special reference to unconjugated hyperbilirubinaemia
35. FINE MAPPING OF A HUMAN CHROMOSOME-6 FERRITIN HEAVY-CHAIN PSEUDOGENE - RELEVANCE TO HEMOCHROMATOSIS
36. ALTERATIONS OF DRUG METABOLISM IN RATS EXPOSED TO CIGARETTE SMOKE
37. Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.
38. THE DIAGNOSIS OF PANCREATITIS
39. Serum Ferritin in Hemochromatosis
40. 4,644 GRAMMES OF ORAL FERROUS SULPHATE (OVER 19 YEARS) WITHOUT APPARENT DAMAGE
41. Iron-overload-related disease in HFE hereditary hemochromatosis.
42. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells
43. Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis.
44. Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.
45. Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
46. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
47. Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
48. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
49. Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests.
50. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.